Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)613
Number of pages1
JournalBreast Cancer Research and Treatment
Volume155
Issue number3
DOIs
StatePublished - Feb 1 2016

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this